Viral infections in renal transplant recipients: an evolutionary problem.
D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000276:immunology / Q000628:therapy; D006084:Graft Rejection; D006525:Hepatitis, Viral, Human / Q000209:etiology; D006561:Herpes Simplex / Q000209:etiology / Q000276:immunology / Q000628:therapy; D006562:Herpes Zoster / Q000209:etiology / Q000628:therapy; D006566:Herpesviridae Infections / Q000209:etiology / Q000276:immunology / Q000628:therapy; D004854:Herpesvirus 4, Human; D006801:Humans; D007116:Immunization, Passive; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation; D011120:Polyomavirus; D011183:Postoperative Complications / Q000209:etiology*; D014412:Tumor Virus Infections / Q000209:etiology; D014777:Virus Diseases / Q000209:etiology*
D000998:Antiviral Agents